# Delivery Order #HT942626FE055

Delivery Order for Novel Broad Spectrum Nanobody by EITR Biologics

**Buyer:** Defense Health Agency

**Award Amount:** $100,000.00
**Ceiling:** $100,000.00

**Awarded:** July 01, 2026
**Period of Performance:** Jul 01, 2026 - Jun 30, 2027

**Identifier:** HT942626FE055
**NAICS:** 541714

This award represents a delivery order under an existing indefinite-delivery contract with EITR Biologics, Inc., a biotechnology company focused on innovative nanomedicine solutions. The contract involves the procurement of a novel bispecific broad spectrum nanobody, reflecting advanced biotherapeutic research and development. This delivery order is significant to the agency’s efforts in developing next-generation medical countermeasures against diverse biological threats, enhancing public health defense. The scope of work covers the design, development, and potential initial testing phases of this novel therapeutic agent. The award follows a strategic continuation of the prior competitive base contract titled 'Novel Nanotherapeutics,' which established a multi-year relationship. The delivery order covers a one-year performance period, demonstrating ongoing commitment to advancing critical nanobody technologies in support of healthcare innovation. No subcontractor or original solicitation details were provided for this specific delivery order.

### Description

NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY

[View original record](https://www.usaspending.gov/award/CONT_AWD_HT942626FE055_9700_HT942523D0011_9700)